 |
Abstract #4 Posted by: ASCODailyNews
Video duration: 95 seconds Howard Scher, MD, provides an update on a phase III study of abiraterone acetate plus prednisone in patients with metastatic castrate-resistant prostate cancer progressing after docetaxel-based chemotherapy. |
 |
Abstract #2 Posted by: ASCODailyNews
Video duration: 55 seconds Neil Fleshner, MD, presents data from the REDEEM study, which shows that dutasteride improves adherence to active surveillance. |
 |
Abstract #7 Posted by: ASCODailyNews
Video duration: 87 seconds The risk of prostate cancer, aggressive prostate cancer, and death from prostate cancer all increase with higher initial PSA values, according to Meelan Bul, MD, of Erasmus MC Rotterdam, The Netherlands. |
 |
Keynote Lecture - Stem Cells and Tumorigenesis in Genitourinary Tumors Posted by: ASCODailyNews
Video duration: 99 seconds Carlos Cordon-Cardo, MD, PhD, of Columbia University, has become an internationally recognized figure in the field of GU cancer research. Recent research from his laboratory has focused on adult stem cells and cancer, and studies have shown that some tumors originate from differentiation stages in stem cell fate and development. |
 |
DP-IMRT with real-time with real-time quality assurance Posted by: ASCODailyNews
Video duration: 65 seconds Abstract 368 - Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal |
 |
A response-guided approach to rare esophogastric cancer using PET Posted by: ASCODailyNews
Video duration: 93 seconds Abstract 3 - PET-guided treatment in locally advanced adenocarcinoma of the esophagogastric junction (AEG): The MUNICON-II study |
 |
Results of Munich Study with ColoPrint Posted by: ASCODailyNews
Video duration: 45 seconds Abstract 358 - Independent validation of a prognostic genomic profile (ColoPrint) for stage II colon cancer (CC) patients |
 |
TKI effects vary despite similar in vitro characteristics Posted by: ASCODailyNews
Video duration: 91 seconds Final results of a University of Chicago phase II consortium trial of sorafenib (SOR) in patients (pts) with imatinib (IM)- and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST) |
![Dr. Miller\](http://img.youtube.com/vi/vUUoSWj1uHk&feature=youtube_gdata/2.jpg "Dr. Miller\") |
Dr. Miller's Bungee Jumps Posted by: ASCODailyNews
Video duration: 115 seconds ASCO member Dr. Kathy Miller Bungee Jumps |
 |
Ezekiel J. Emanuel, MD, PhD - Overview of Health Care Reform (Part 2 of 2) Posted by: ASCODailyNews
Video duration: 900 seconds Ezekiel J. Emanuel, MD, PhD, presents an overview of health care reform during the 2010 Breast Cancer Symposium. |
 |
Ezekiel J. Emanuel, MD, PhD - Overview of Health Care Reform (Part 1 of 2) Posted by: ASCODailyNews
Video duration: 906 seconds Ezekiel J. Emanuel, MD, PhD, presents an overview of health care reform during the 2010 Breast Cancer Symposium. |
 |
2010 Gianni Bonadonna Breast Cancer Award and Lecture Posted by: ASCODailyNews
Video duration: 177 seconds 2010 Gianni Bonadonna Breast Cancer Award recipient Dr. Nancy E. Davidson discusses epigenetic gene silencing in breast cancer. |
 |
ASCO CEO Allen Lichter, MD - Impact of Health Care Reform on Oncology Practice (Part 2 of 2) Posted by: ASCODailyNews
Video duration: 741 seconds ASCO CEO Allen Lichter, MD, discusses "Impact of Health Care Reform on Oncology Practice" during the 2010 Breast Cancer Symposium. |
 |
ASCO CEO Allen Lichter, MD - Impact of Health Care Reform on Oncology Practice (Part 1 of 2) Posted by: ASCODailyNews
Video duration: 881 seconds ASCO CEO Allen Lichter, MD, discusses "Impact of Health Care Reform on Oncology Practice" during the 2010 Breast Cancer Symposium. |
 |
Breast Cancer Symposium - Olson (Abstract 91) Posted by: ASCODailyNews
Video duration: 149 seconds John Olson, MD, of Duke University, presents results from ACOSOG Z1031 during the 2010 Breast Cancer Symposium. |
![Excerpt from Breast Cancer Local - Oral Abstract Session at ASCO\](http://img.youtube.com/vi/Jnq-LVlgyIw&feature=youtube_gdata/2.jpg "Excerpt from Breast Cancer Local - Oral Abstract Session at ASCO\") |
Excerpt from Breast Cancer Local - Oral Abstract Session at ASCO's 2010 Annual Meeting Posted by: ASCODailyNews
Video duration: 117 seconds Armando Guiliano, MD, discusses trial results. |
![Excerpt from the Plenary Session at ASCO\](http://img.youtube.com/vi/tI-1v0vRCwg&feature=youtube_gdata/2.jpg "Excerpt from the Plenary Session at ASCO\") |
Excerpt from the Plenary Session at ASCO's 2010 Annual Meeting Posted by: ASCODailyNews
Video duration: 113 seconds Robert A. Burger, MD, discusses advances in the treatment of ovarian cancer. |
 |
Excerpt from The Presidential Address Posted by: ASCODailyNews
Video duration: 648 seconds ASCO 2010 Presidential Address Excerpt: Douglas W. Blayney, M.D. |
 |
Excerpt from the Molecularly Targeted Trials in Lung Cancer Clinical Science Symposia Posted by: ASCODailyNews
Video duration: 106 seconds Joan Schiller, MD, reports Results from ARQ 197-209 at the 2010 ASCO Annual Meeting. |
 |
Excerpt from Advances in Prevention of Major Malignancies Education Session Posted by: ASCODailyNews
Video duration: 74 seconds Ian Thompson, MD, discusses chemoprevention of prostate cancer during ASCO's 2010 Annual Meeting. |
